Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2/3, Multi-Center, Open Label Study of Efficacy, Safety, and Pharmacokinetics of PEGylated Recombinant Factor VIII (BAX 855) Administered for Prophylaxis and Treatment of Bleeding in Previously Treated Patients With Severe Hemophilia A

Next Previous
X
Search
Trial Profile

A Phase 2/3, Multi-Center, Open Label Study of Efficacy, Safety, and Pharmacokinetics of PEGylated Recombinant Factor VIII (BAX 855) Administered for Prophylaxis and Treatment of Bleeding in Previously Treated Patients With Severe Hemophilia A

Status: Completed
Phase of Trial: Phase II/III

Latest Information Update: 13 Dec 2022

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Rurioctocog alfa pegol (Primary) ; Octocog alfa
  • Indications Haemophilia A
  • Focus Registrational; Therapeutic Use
  • Acronyms PROLONG-ATE
  • Sponsors Baxalta; Baxter Healthcare Corporation

    • Most Recent Events

    • 03 Feb 2021 According to a Takeda media release, data from this study are being presented at the Virtual European Association for Haemophilia and Allied Disorders Congress (EAHAD 2021).
    • 05 Feb 2020 According to a Takeda media release, pooled data from this and other five trials (NCT01599819, NCT01913405, NCT01945593, NCT02210091, NCT02585960) is being presented at the 13th Annual Congress of the European Association for Haemophilia and Allied Disorders, EAHAD 2020.
    • 18 Jul 2019 This trial has been completed in Romania, according to European Clinical Trials Database

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top